Skip to main content

Highlights

  1. 1
    The Journal of thoracic and cardiovascular surgery · 2022
    PMID: 36028357DOIFirst author19 citations

Publications

65 publications

Clinical research

1 study
Completed & closed trials (1)
  • PI
    A Phase III, Double-blind, Randomised, Placebo-Controlled, International Study to Assess the Efficacy and Safety of Adjuvant Osimertinib Versus Placebo in Participants With EGFR Mutation-positive Stage IA2-IA3 Non-small Cell Lung Cancer, Following Complete Tumour Resection
    PHASE3 · AstraZeneca Pharmaceuticals LP · CLOSED TO ACCRUAL (as of 2024)
    Non-Small Cell Lung Cancer
    NCT05120349

External relationships

Other

AstraZeneca Pharmaceuticals LP · Laborie Medical Technologies Corp